Launchit Solutions
Andrew Haller is an accomplished professional with extensive experience in the fields of biotechnology, pharmacology, and business development. Currently serving as an Editor at Mednet and a Partner in Business Development at Launchit Solutions, Andrew plays a strategic role in several startups within the LaunchIt Ventures portfolio. In addition, Andrew holds advisory and board positions with ventureLAB and BioCacheโข Lab Solutions, respectively, while acting as Principal at Accelerant Biotech Consulting, providing expertise in business development strategy and market research. As an Adjunct Lecturer at the University of Toronto's Faculty of Medicine, Andrew focuses on drug development, AI applications in medicine, and entrepreneurship in bio-innovation. Previously, Andrew was the Founder and CEO of Phoenox Pharma, and has contributed significantly to clinical trials through roles at Clinical Trials Ontario. Andrew possesses a Ph.D. in Molecular Pharmacology and Cancer Therapeutics from the University at Buffalo, along with graduate and undergraduate qualifications in toxicology and biochemistry.
This person is not in any teams
Launchit Solutions
Launchit Solutions is a venture studio that builds and commercializes novel HealthTech innovations. As a venture studio, we go beyond funding to provide a team that can take on the entire process of refining and idea, building the product or service, setting up the legal entity and intellectual property agreements, and taking it to market. Our shared services team provides common back-office support, including finance, bookkeeping, legal, insurance, HR, and administrative services. The involvement of the studio throughout the entire growth process offers a much more predictable path to success. Our team of seasoned entrepreneurs has what it takes to successfully launch these novel ventures.